| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |